CN111840383A - Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof - Google Patents
Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof Download PDFInfo
- Publication number
- CN111840383A CN111840383A CN202010853302.9A CN202010853302A CN111840383A CN 111840383 A CN111840383 A CN 111840383A CN 202010853302 A CN202010853302 A CN 202010853302A CN 111840383 A CN111840383 A CN 111840383A
- Authority
- CN
- China
- Prior art keywords
- moxibustion
- pot
- root
- composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 239000007921 spray Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 9
- 201000003068 rheumatic fever Diseases 0.000 title abstract description 14
- 208000002193 Pain Diseases 0.000 claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 23
- 229910052796 boron Inorganic materials 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims abstract description 12
- 229910052805 deuterium Inorganic materials 0.000 claims abstract description 12
- 238000011049 filling Methods 0.000 claims abstract description 10
- 241000287127 Passeridae Species 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000007789 sealing Methods 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract 3
- 241000241550 Cyathula Species 0.000 claims abstract 2
- 238000005507 spraying Methods 0.000 claims description 17
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000004863 Frankincense Substances 0.000 claims description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000010978 jasper Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000004927 clay Substances 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000004575 stone Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000000052 vinegar Substances 0.000 claims description 4
- 235000021419 vinegar Nutrition 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 241000213006 Angelica dahurica Species 0.000 claims description 2
- 241000758794 Asarum Species 0.000 claims description 2
- 241000255789 Bombyx mori Species 0.000 claims description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 2
- 241000725145 Homalomena Species 0.000 claims description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 2
- 241001254604 Angelica pubescens Species 0.000 claims 2
- 244000020518 Carthamus tinctorius Species 0.000 claims 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims 2
- 241000218158 Clematis Species 0.000 claims 2
- 241000208688 Eucommia Species 0.000 claims 2
- 241000427159 Achyranthes Species 0.000 claims 1
- 241000489492 Arisaema Species 0.000 claims 1
- 244000189799 Asimina triloba Species 0.000 claims 1
- 235000006264 Asimina triloba Nutrition 0.000 claims 1
- 241000132012 Atractylodes Species 0.000 claims 1
- 235000003717 Boswellia sacra Nutrition 0.000 claims 1
- 240000007551 Boswellia serrata Species 0.000 claims 1
- 235000012035 Boswellia serrata Nutrition 0.000 claims 1
- 241000131329 Carabidae Species 0.000 claims 1
- 235000009467 Carica papaya Nutrition 0.000 claims 1
- 240000007311 Commiphora myrrha Species 0.000 claims 1
- 241000123589 Dipsacus Species 0.000 claims 1
- 241000218671 Ephedra Species 0.000 claims 1
- 235000014066 European mistletoe Nutrition 0.000 claims 1
- 241000501743 Gentiana macrophylla Species 0.000 claims 1
- 241000112528 Ligusticum striatum Species 0.000 claims 1
- 241000488974 Loranthus Species 0.000 claims 1
- 235000017784 Mespilus germanica Nutrition 0.000 claims 1
- 241000361919 Metaphire sieboldi Species 0.000 claims 1
- 244000182216 Mimusops elengi Species 0.000 claims 1
- 235000000560 Mimusops elengi Nutrition 0.000 claims 1
- 240000000249 Morus alba Species 0.000 claims 1
- 235000008708 Morus alba Nutrition 0.000 claims 1
- 244000236658 Paeonia lactiflora Species 0.000 claims 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims 1
- 241000405414 Rehmannia Species 0.000 claims 1
- 244000152640 Rhipsalis cassutha Species 0.000 claims 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims 1
- 241001077909 Sigesbeckia Species 0.000 claims 1
- 235000007837 Vangueria infausta Nutrition 0.000 claims 1
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 235000006886 Zingiber officinale Nutrition 0.000 claims 1
- 229940107666 astragalus root Drugs 0.000 claims 1
- 235000008397 ginger Nutrition 0.000 claims 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 claims 1
- 239000011028 pyrite Substances 0.000 claims 1
- 229910052683 pyrite Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 239000003814 drug Substances 0.000 abstract description 25
- 241001489978 Eupolyphaga Species 0.000 abstract description 6
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 235000015816 nutrient absorption Nutrition 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 19
- 230000008961 swelling Effects 0.000 description 19
- 208000006820 Arthralgia Diseases 0.000 description 15
- 241000903946 Clematidis Species 0.000 description 10
- 241000628997 Flos Species 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 230000000202 analgesic effect Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000255791 Bombyx Species 0.000 description 5
- 241000717739 Boswellia sacra Species 0.000 description 5
- 239000009636 Huang Qi Substances 0.000 description 5
- 241000243684 Lumbricus Species 0.000 description 5
- 241001057584 Myrrha Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 240000001307 Myosotis scorpioides Species 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- -1 boron ions Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023215 Joint effusion Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- JZLOKWGVGHYBKD-UHFFFAOYSA-M sodium;2-acetyloxybenzoate Chemical compound [Na+].CC(=O)OC1=CC=CC=C1C([O-])=O JZLOKWGVGHYBKD-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000011031 topaz Substances 0.000 description 1
- 229910052853 topaz Inorganic materials 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
- A61H2201/105—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Rehabilitation Therapy (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Animal Husbandry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a targeted moxibustion composition for treating rheumatic arthritis, which comprises a pot A and a pot B, wherein the pot A comprises Kunlun Muyu powder, radix angelicae pubescentis, pseudo-ginseng and the like, and the pot B comprises cassia twig, eupolyphaga, medicinal cyathula root and the like. Adding auxiliary materials into the traditional Chinese medicine components, stirring uniformly, adding the mixture into a specific container, sealing with yellow mud, baking at 35-65 ℃, then carrying out low-temperature ultra-micro nano-nano pulverization, diluting with high-boron deuterium-depleted water, pressurizing, filling and preparing into spray. The invention firstly sprays A pot on Shenshu, Zhongwan and Shenque acupoints, adopts sparrow pecking moxibustion and mild moxibustion to carry out moxibustion alternately, and then sprays B pot on the pain position for moxibustion. The Kunlun Muyu powder is specially added, so that the cell microcirculation can be improved, the nutrient absorption is promoted, other nano-scale traditional Chinese medicine particles are directly absorbed through skin penetration, the effective components of the medicine are quickly permeated through the spray moxibustion therapy, and the traditional Chinese medicine composition has a good treatment effect on the rheumatic arthritis.
Description
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to a targeted moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof.
Background
Rheumatoid arthritis is a common acute or chronic inflammation of connective tissue characterized by wandering soreness and redness and swelling of joints and muscles. The joint is characterized in that phalanges are tightly connected with each other by virtue of dense fibrous connective tissues, joint surfaces at the joint of the phalanges are generally a convex surface and a concave surface, a closed joint cavity is formed in the middle of the phalanges, joint liquid is contained in the joint cavity, and when the joint is diseased, the liquid in the joint cavity is increased to form joint effusion and swelling. The closed structure of the joint makes traditional medicines difficult to enter, which is the root cause of stubborn and intractable rheumatoid arthritis. Most western medicines relieve pain through paralysis, and have no specific effect on treating symptoms and root causes, and the treatment of the rheumatoid arthritis is not available.
Therefore, the treatment medicine and the treatment method thereof which solve the root problems, have good effects and no side effects are urgently needed by the majority of patients with the rheumatic arthritis.
Disclosure of Invention
Aiming at the technical background, the technical problem to be solved by the invention is to provide a targeted moxibustion spraying composition for treating rheumatic arthritis, which adopts a direct transdermal absorption mode, Kunlun Cuiyu powder in a tank A can improve cell microcirculation and promote drug absorption, is matched with nano-scale traditional Chinese medicine particles in a tank B to directly act on pain parts in a targeted mode, and combines the moxibustion spraying therapy to quickly permeate active ingredients of the medicine, enhance the drug effect and achieve better effect.
In order to solve the technical problems, the invention adopts the technical scheme that:
a targeted spray moxibustion composition for treating rheumatic arthritis comprises jar A and jar B, wherein jar A comprises Kunlun Muyu powder, radix Angelicae Pubescentis, radix Notoginseng, radix Angelicae sinensis, flos Carthami, ramulus Cinnamomi, radix Clematidis, herba Taxilli, cortex Eucommiae, radix Angelicae Dahuricae, herba asari, radix Paeoniae alba, and radix astragali, jar B comprises ramulus Cinnamomi, Eupolyphaga Seu Steleophaga, radix Cyathulae, radix Achyranthis bidentatae, rhizoma Atractylodis, herba Ephedrae, Bombyx Batryticatus, Olibanum, Myrrha, Pyritum preparata, radix Angelicae sinensis, flos Carthami, rhizoma Ligustici Chuanxiong, cortex Schizophragmatis Integrifolii Radicis, rhizoma Notopterygii, rhizoma Zingiberis, radix Stephaniae Tetrandrae, radix Clematidis, fructus Lycii, cortex Eucommiae, radix Gentianae Macrophyllae, rhizoma homalomenae, rhizoma arisaematis, Siegesbeckiae herba, fructus Chaenomelis, Lumbricus, radix Angelicae Pubescentis, radix Dipsaci.
Preferably, the components are mixed according to the parts by weight:
and (4) tank A:
and (4) tank B:
a preparation method of a targeted moxibustion composition for treating rheumatoid arthritis comprises the following steps:
s01: baking with slow fire: weighing the components of the composition according to the weight part ratio, cleaning, adding auxiliary materials, stirring uniformly, adding into a container fired by adding clay, medical stone powder and jasper powder, sealing with yellow mud, and baking in a baking room at 35-65 ℃;
s02: nano-crushing: adding high-boron deuterium-depleted water, and micronizing at 25 deg.C to obtain suspension containing Chinese medicinal particles with nanometer particle size;
s03: and (3) sterilization and filling: short-time microwave sterilization, high-boron deuterium-depleted water dilution, pressurization filling and spray preparation.
Preferably, the auxiliary materials in the S01 include one or more of honey, yellow wine, bran, salt and vinegar.
A targeted spray moxibustion composition for treating rheumatic arthritis is prepared by spraying pot A on Shenshu, Zhongwan and Shenque acupoints, alternately performing moxibustion by sparrow pecking and mild moxibustion for 10-30 min, and spraying pot B on the pain area for 10-30 min.
The invention has the advantages that:
(1) the specially added Kunlun jasper powder has the effect of improving cell microcirculation and promotes the absorption capacity of cells to medicinal components;
(2) the traditional Chinese medicine components are baked by slow fire to increase the drug effect, and then are pulverized at low temperature to be nano-scale particle size, so that the traditional Chinese medicine components can be directly absorbed through skin;
(3) the invention adopts the combination of the pot A and the pot B, which can cure and maintain the disease, consolidate the curative effect and prevent the recurrence.
Detailed Description
The technical solution of the present invention is described below clearly and completely with reference to specific embodiments, and it is obvious that the described embodiments are only some embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a technical scheme that: a targeted spray moxibustion composition for treating rheumatic arthritis comprises jar A and jar B, wherein jar A comprises Kunlun Muyu powder, radix Angelicae Pubescentis, radix Notoginseng, radix Angelicae sinensis, flos Carthami, ramulus Cinnamomi, radix Clematidis, herba Taxilli, cortex Eucommiae, radix Angelicae Dahuricae, herba asari, radix Paeoniae alba, and radix astragali, jar B comprises ramulus Cinnamomi, Eupolyphaga Seu Steleophaga, radix Cyathulae, radix Achyranthis bidentatae, rhizoma Atractylodis, herba Ephedrae, Bombyx Batryticatus, Olibanum, Myrrha, Pyritum preparata, radix Angelicae sinensis, flos Carthami, rhizoma Ligustici Chuanxiong, cortex Schizophragmatis Integrifolii Radicis, rhizoma Notopterygii, rhizoma Zingiberis, radix Stephaniae Tetrandrae, radix Clematidis, fructus Lycii, cortex Eucommiae, radix Gentianae Macrophyllae, rhizoma homalomenae, rhizoma arisaematis, Siegesbeckiae herba, fructus Chaenomelis, Lumbricus, radix Angelicae Pubescentis, radix Dipsaci.
The components are mixed according to the parts by weight:
and (4) tank A:
and (4) tank B:
the main components have the following functions in the system:
kunlun black jade powder: through scientific detection, the Kunlun Muyu powder contains more than thirty mineral substances and trace elements which are beneficial to the human body, and can permeate into cells of the human body for a long time, keep the balance of various elements in the human body and achieve the effects of removing diseases and building the body; the far infrared microwave emission can improve cell microcirculation, enhance cell activity, promote cell metabolism and promote absorption of medicinal components by cells.
Radix angelicae pubescentis: pungent, bitter and slightly warm. It enters liver, kidney and bladder meridians. It has the effects of wind-cold-dampness arthralgia, is pungent, bitter and dry in property, fragrant and warm in smell, good in dispelling wind-damp and relieving arthralgia, is a main drug for treating rheumatic arthralgia, and can be applied to arthralgia syndrome caused by wind-cold-dampness for any time; it enters kidney meridian and descends, so it is indicated for arthralgia due to wind-cold-dampness in lower part of waist, knee, leg and foot due to its good property, and it is indicated for arthralgia due to wind-cold-dampness.
Chinese angelica: sweet, pungent and warm, enter liver, heart and spleen meridians. It has antiinflammatory and analgesic effects, and can inhibit acute capillary permeability increase, tissue edema and chronic injury caused by various inflammatory agents, and inhibit granulation tissue hyperplasia in late stage of inflammation without affecting weight of adrenal gland and thymus, and its antiinflammatory effect is independent of pituitary-adrenal gland system. The water extract of angelica shows analgesic effect on writhing reaction caused by intraperitoneal injection of acetic acid, and the analgesic effect strength is 1.7 times of that of sodium acetylsalicylate.
Asarum: pungent and warm. It enters heart, lung and kidney meridians. Relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, dredging orifices, warming lung, and eliminating phlegm. Can be used for treating common cold due to wind-cold, headache, toothache, nasal obstruction, nasal discharge, allergic rhinitis, nasosinusitis, rheumatic arthralgia, phlegm and fluid retention, and cough and asthma.
Achyranthes bidentata: ganmaosuan, cool, enter heart, liver and large intestine meridians. Promoting blood circulation, removing blood stasis, eliminating dampness, promoting urination, and relieving inflammation and pain.
Rhizoma atractylodis: bran rhizoma atractylodis, pungent and bitter with warm nature. It enters spleen, stomach and liver meridians. Dry dampness and invigorate spleen, dispel wind and cold, improve vision. Can be used for treating abdominal distention, diarrhea, edema, rheumatalgia, and wind-cold type common cold.
Stiff silkworm: is a common traditional Chinese medicine, has the efficacies of dispelling wind, relieving spasm, reducing phlegm and resolving masses, and is clinically used for treating tangible masses, such as nodules, sore throat, scrofula, urticaria and the like, and the effect of dredging and dispersing the masses is achieved.
Myrrh: bitter and mild in taste, non-toxic, entering liver, spleen, heart and kidney meridians. Can be used for treating blood stasis and pain in chest and abdomen, dysmenorrhea, amenorrhea, abdominal mass, traumatic injury, carbuncle, skin ulcer, intestinal carbuncle, conjunctival congestion, and swelling and pain; has effects in promoting blood circulation, relieving pain, eliminating swelling, and promoting granulation; blood-activating and stasis-resolving herbs.
Calcining Pyritum: when used together, Ru Xiang can promote blood circulation and dissipate blood stasis, and relieve swelling and pain, and can be used for treating blood stasis and swelling pain due to traumatic injury.
Large-leaved gentian: pungent, bitter and mild. It enters stomach, liver and gallbladder meridians. It is mainly used for dispelling wind-damp, clearing damp-heat and stopping arthralgia.
Obscured homalomena rhizome: being pungent in property and warm in nature, it enters liver, kidney and stomach meridians. Has effects in dispelling pathogenic wind and dampness, relaxing muscles and tendons, activating collateral flow, relieving pain, and relieving swelling. It can be used for treating rheumatalgia, soreness of limbs, flaccidity of bones and muscles, traumatic injury, gastralgia, superficial infection, sore, and swelling.
Radix aconiti: pungent, bitter and hot in flavor, enter heart, liver, kidney and spleen meridians. It is used for treating arthralgia due to wind-cold-dampness, arthralgia, psychroalgia of heart and abdomen, and cold hernia. Can be used for treating arthralgia due to wind-cold-dampness and arthralgia.
Kusnezoff monkshood root: pungent and bitter in flavor and warm in nature, enter heart, liver, kidney and spleen meridians, dispel wind and dampness, warm meridians and relieve pain.
Licorice root: the famous Chinese medicine ceramic carries a landscape which is given as follows: for the old, Licorice is also called as the beauty. Licorice root, radix Glycyrrhizae harmonizes with other herbs to make it dispute, it is known as "Shi Fang Ji Cao" . Licorice, sweet in taste, has the effects of invigorating spleen, benefiting qi, moistening lung, relieving cough, relieving spasm and pain, can harmonize the medicines and alleviate the side effects of the violent medicines, and is widely used in clinical formulas.
A preparation method of a targeted moxibustion composition for treating rheumatoid arthritis comprises the following steps:
s01: baking with slow fire: weighing the components of the composition according to the weight part ratio, cleaning, adding auxiliary materials, stirring uniformly, adding into a container fired by adding clay, medical stone powder and jasper powder, sealing with yellow mud, and baking in a baking room at 35-65 ℃;
s02: nano-crushing: adding high-boron deuterium-depleted water, and micronizing at 25 deg.C to obtain suspension containing Chinese medicinal particles with nanometer particle size;
s03: and (3) sterilization and filling: short-time microwave sterilization, high-boron deuterium-depleted water dilution, pressurization filling and spray preparation.
S01 the adjuvants include one or more of Mel, yellow wine, testa Tritici, salt, and vinegar.
The traditional Chinese medicine components are baked by slow fire to increase the drug effect, and then are subjected to an ultramicro nano-pulverization technology, a high-speed air vortex is utilized to form an air knife, substances are subjected to ultramicro-granulation at a low temperature below 25 ℃, the original molecular structure of the substances is not damaged, the effect of the substances is retained to the greatest extent, the obtained traditional Chinese medicine particles are nano-sized and can be completely suspended in spray liquid, the diameter of pores is about 20-50 microns, the nano-sized traditional Chinese medicine particles can be directly absorbed through the skin, the permeability is good, and the problem that the common traditional Chinese medicine components are large in particle size and are not easy to absorb is solved. The obtained nanoscale Kunlun Muyu powder can effectively improve cell microcirculation, promote metabolism, promote absorption of cells to other traditional Chinese medicine components, directly target the pain part, and radically solve the problem of rheumatoid arthritis.
The high-boron deuterium-depleted water is adopted for dilution, researches show that the deuterium-depleted water can promote the activity of enzymes in the body, enhance the immunity of the body, effectively remove acidic waste in blood, improve the internal environment, enhance the cell activity, promote the cell metabolism and promote the absorption of nutrient substances, meanwhile, boron ions have the bacteriostatic effect, the boron ions can effectively enhance the drug effect when being used as a diluent of the moxibustion spraying composition, and the high-boron deuterium-depleted water is used for dilution and is beneficial to filling and spraying.
A targeted spray moxibustion composition for treating rheumatic arthritis is prepared by spraying pot A on Shenshu, Zhongwan and Shenque acupoints, alternately performing moxibustion by sparrow pecking and mild moxibustion for 10-30 min, and spraying pot B on the pain area for 10-30 min.
Shenshu points: kidneys are the innate root, store essence, govern bones, strengthen sense organs and have the function of strengthening adrenal glands. Moxibustion for treating the acupoints has therapeutic effects on nephropathy, osteopathia, endocrine diseases, immune system diseases and the like, and is a necessary choice for physiotherapy for treating rheumatism.
Zhongwan acupoint: the spleen and stomach are involved in the coordination of the stomach meridian. The transportation and transformation not only refers to the transportation and application of the food essence, but also includes the absorption and removal of pathological substances in the body. If the area is frequently moxibustion, the absorption and digestion functions of people are vigorous, the metabolism capability is improved, and the pathological tissues are rapidly repaired.
The Shenque point: it is the Shenqi point and the root of the disease. The acupuncture points are treated by moxibustion, have the functions of promoting and regulating the functions of internal organs, and are indispensable to treat diseases such as endocrine system, autoimmune system, deficiency, weakness and the like.
The nanometer Kunlun jasper powder in the tank A acts on the acupuncture points in a transdermal manner, so that microcirculation can be improved, cell activity can be enhanced, cell metabolism can be promoted, and absorption of cells to other traditional Chinese medicine components can be promoted, so that the active ingredients of the traditional Chinese medicine in the tank B can be effectively exerted, absorbed in a transdermal manner and directly acted on pain parts in a targeted manner; after the two times of spraying, alternate moxibustion treatment is carried out by adopting sparrow pecking moxibustion and mild moxibustion, so that the effective components of the medicine can quickly permeate to the action part, the medicine effect is enhanced, and the effect is better.
Example 1
A targeted spray moxibustion composition for treating rheumatic arthritis comprises jar A and jar B, wherein jar A comprises Kunlun Muyu powder, radix Angelicae Pubescentis, radix Notoginseng, radix Angelicae sinensis, flos Carthami, ramulus Cinnamomi, radix Clematidis, herba Taxilli, cortex Eucommiae, radix Angelicae Dahuricae, herba asari, radix Paeoniae alba, and radix astragali, jar B comprises ramulus Cinnamomi, Eupolyphaga Seu Steleophaga, radix Cyathulae, radix Achyranthis bidentatae, rhizoma Atractylodis, herba Ephedrae, Bombyx Batryticatus, Olibanum, Myrrha, Pyritum preparata, radix Angelicae sinensis, flos Carthami, rhizoma Ligustici Chuanxiong, cortex Schizophragmatis Integrifolii Radicis, rhizoma Notopterygii, rhizoma Zingiberis, radix Stephaniae Tetrandrae, radix Clematidis, fructus Lycii, cortex Eucommiae, radix Gentianae Macrophyllae, rhizoma homalomenae, rhizoma arisaematis, Siegesbeckiae herba, fructus Chaenomelis, Lumbricus, radix Angelicae Pubescentis, radix Dipsaci.
The components are mixed according to the parts by weight:
and (4) tank A:
and (4) tank B:
the composition is prepared by adopting the following steps:
s01: baking with slow fire: weighing the components of the composition according to the weight part ratio, cleaning, adding auxiliary materials, stirring uniformly, adding into a container fired by adding clay, medical stone powder and jasper powder, sealing with yellow mud, and baking in a baking room at 35-65 ℃;
s02: nano-crushing: adding high-boron deuterium-depleted water, and micronizing at 25 deg.C to obtain suspension containing Chinese medicinal particles with nanometer particle size;
s03: and (3) sterilization and filling: short-time microwave sterilization, high-boron deuterium-depleted water dilution, pressurization filling and spray preparation.
S01 the adjuvants include one or more of Mel, yellow wine, testa Tritici, salt, and vinegar.
The application method of the spray moxibustion composition comprises the steps of firstly spraying the pot A to act on Shenshu, Zhongwan and Shenque acupoints, carrying out moxibustion by adopting sparrow pecking moxibustion and mild moxibustion alternately, treating each acupoint for 10-30 minutes, and then uniformly spraying the pot B on the pain part for 10-30 minutes.
Example 2
A targeted spray moxibustion composition for treating rheumatic arthritis comprises jar A and jar B, wherein jar A comprises Kunlun Muyu powder, radix Angelicae Pubescentis, radix Notoginseng, radix Angelicae sinensis, flos Carthami, ramulus Cinnamomi, radix Clematidis, herba Taxilli, cortex Eucommiae, radix Angelicae Dahuricae, herba asari, radix Paeoniae alba, and radix astragali, jar B comprises ramulus Cinnamomi, Eupolyphaga Seu Steleophaga, radix Cyathulae, radix Achyranthis bidentatae, rhizoma Atractylodis, herba Ephedrae, Bombyx Batryticatus, Olibanum, Myrrha, Pyritum preparata, radix Angelicae sinensis, flos Carthami, rhizoma Ligustici Chuanxiong, cortex Schizophragmatis Integrifolii Radicis, rhizoma Notopterygii, rhizoma Zingiberis, radix Stephaniae Tetrandrae, radix Clematidis, fructus Lycii, cortex Eucommiae, radix Gentianae Macrophyllae, rhizoma homalomenae, rhizoma arisaematis, Siegesbeckiae herba, fructus Chaenomelis, Lumbricus, radix Angelicae Pubescentis, radix Dipsaci.
The components are mixed according to the parts by weight:
and (4) tank A:
and (4) tank B:
the preparation and use methods are the same as above.
Example 3
A targeted spray moxibustion composition for treating rheumatic arthritis comprises jar A and jar B, wherein jar A comprises Kunlun Muyu powder, radix Angelicae Pubescentis, radix Notoginseng, radix Angelicae sinensis, flos Carthami, ramulus Cinnamomi, radix Clematidis, herba Taxilli, cortex Eucommiae, radix Angelicae Dahuricae, herba asari, radix Paeoniae alba, and radix astragali, jar B comprises ramulus Cinnamomi, Eupolyphaga Seu Steleophaga, radix Cyathulae, radix Achyranthis bidentatae, rhizoma Atractylodis, herba Ephedrae, Bombyx Batryticatus, Olibanum, Myrrha, Pyritum preparata, radix Angelicae sinensis, flos Carthami, rhizoma Ligustici Chuanxiong, cortex Schizophragmatis Integrifolii Radicis, rhizoma Notopterygii, rhizoma Zingiberis, radix Stephaniae Tetrandrae, radix Clematidis, fructus Lycii, cortex Eucommiae, radix Gentianae Macrophyllae, rhizoma homalomenae, rhizoma arisaematis, Siegesbeckiae herba, fructus Chaenomelis, Lumbricus, radix Angelicae Pubescentis, radix Dipsaci.
The components are mixed according to the parts by weight:
and (4) tank B:
the preparation and use methods are the same as above.
Comparative example 1
Tank a contained no kunlun topaz powder, and the rest was the same as in example 2.
Comparative example 2
The composition in the example 2 is directly and commonly ground without being baked by slow fire, sieved by a 100-mesh sieve, sterilized and filled, and the rest are the same.
Comparative example 3
The composition of example 2 was applied to the human body in both tank A and tank B, and the rest were the same.
The compositions for moxibustion according to the invention are further described below by means of animal tests and tests of clinical effectiveness.
First, animal experiment
(one) detumescence Effect test
1. Preparation of mouse pinna swelling model: 70 adult mice weighing 200-300 g were randomly divided into seven groups, each group corresponding to the test of the above-mentioned spray moxibustion composition prepared in examples 1-3 and the spray moxibustion composition prepared in comparative examples 1-3, and the remaining group was a control group. A microinjector was used to drop 0.02mL of xylene into the right ear of the mouse and the xylene was allowed to saturate both sides of the mouse ear, and the left ear was used as a control. Except for a control group, the other groups are treated by adopting corresponding moxibustion spraying compositions, the mouse is killed by pulling the neck after 2h, two ears are cut along the base line of the auricle, ear sheets are punched at the symmetrical parts of the left ear and the right ear by adopting a 6 mm-diameter puncher, the mass of each mouse ear is weighed by using a precise electronic balance, and the swelling rate and the inhibition rate of the mouse ear are calculated by the following calculation formula:
swelling rate ═ mass of right ear-mass of left ear)/mass of left ear × 100%
Inhibition rate ═ degree of control group auricle swelling-degree of experimental group auricle swelling)/degree of control group auricle swelling × 100%
2. Statistics of results
Group of | n | Degree of auricle swelling (mg) | Inhibition ratio (%) |
Control group | 10 | 32.79±10.11 | —— |
Example 1 | 10 | 12.08±8.53 | 63.16 |
Example 2 | 10 | 8.36±6.98 | 74.50 |
Example 3 | 10 | 10.28±6.37 | 68.65 |
Comparative example 1 | 10 | 20.37±6.42 | 37.88 |
Comparative example 2 | 10 | 22.38±11.58 | 31.74 |
Comparative example 3 | 10 | 18.66±15.71 | 43.09 |
The higher the inhibition value, the more effective the elimination effect on the swelling of mouse auricle. As can be seen from the above table, the moxibustion spray compositions prepared in the examples have higher inhibition rate and more obvious detumescence effect compared with the comparative examples.
(II) analgesic Activity test
1. Mouse acetic acid writhing experiment: 70 adult mice weighing 200-300 g were randomly divided into seven groups, each group corresponding to the test of the above-mentioned spray moxibustion composition prepared in examples 1-3 and the spray moxibustion composition prepared in comparative examples 1-3, and the remaining group was a control group. Injecting 0.7% HAC normal saline 0.2mL into abdominal cavity of each mouse, treating the rest groups except the control group with corresponding moxibustion spraying composition, recording the times of mouse writhing reaction within 20min, and calculating the percentage of analgesic inhibition, wherein the calculation formula is as follows:
percent (%) pain (number of writhing response in control group-number of writhing response in experimental group)/number of writhing response in control group × 100%
2. Statistics of results
Group of | n | Number of wriggling reactions | Inhibition ratio (%) |
Control group | 10 | 60.3±6.3 | —— |
Example 1 | 10 | 20.6±8.4 | 65.8 |
Example 2 | 10 | 16.5±7.9 | 72.6 |
Example 3 | 10 | 18.9±6.7 | 68.7 |
Comparative example 1 | 10 | 40.7±6.2 | 32.5 |
Comparative example 2 | 10 | 42.8±10.5 | 29.0 |
Comparative example 3 | 10 | 38.6±11.1 | 36.0 |
The higher the percentage analgesic value, the more obvious the analgesic effect. As can be seen from the above table, the moxibustion spray compositions prepared in the examples have higher inhibition rate and better analgesic effect than the comparative examples.
Second, clinical efficacy testing
The effect test was carried out on the above-mentioned spray moxibustion compositions prepared in examples 1 to 3 and the spray moxibustion compositions prepared in comparative examples 1 to 3.
300 patients with rheumatoid arthritis were randomly assigned into six groups, and the moxibustion composition prepared in examples 1 to 3 and the moxibustion composition prepared in comparative examples 1 to 3 were used 2 times a day for 1 month continuously, and the statistical results of the therapeutic effects were shown in the following table.
The judgment standard of the curative effect condition is as follows:
obvious effect-ache and red swelling are obviously relieved or healed, and the value of O resistance is greatly reduced or recovered to be normal;
effective-ache and red swelling are relieved, and the anti-O value is reduced;
ineffectiveness, pain, redness and swelling did not change significantly or tended to worsen, and the anti "O" value did not decrease or tended to increase.
Group of | n | Show effect | Is effective | Invalidation | Total effective rate |
Example 1 | 50 | 40 | 6 | 4 | 92% |
Example 2 | 50 | 45 | 5 | 0 | 100% |
Example 3 | 50 | 42 | 6 | 2 | 96% |
Comparative example 1 | 50 | 26 | 8 | 16 | 68% |
Comparative example 2 | 50 | 15 | 10 | 25 | 50% |
Comparative example 3 | 50 | 28 | 9 | 13 | 74% |
As can be seen from the above table, compared with the comparative examples, the effective rates of the moxibustion spray compositions prepared in the examples are higher in terms of rheumatoid arthritis, all of which are above 90%, and no adverse reaction occurs in the test period of the moxibustion spray composition, which indicates that the moxibustion spray composition has a significant effect in terms of treating rheumatoid arthritis.
Typical cases are:
1. in the case of a certain Liangqi, male, 55 years old, more than three years old of joint and muscle wandering ache and red swelling, inconvenient movement and serious influence on daily life, the spraying moxibustion composition of the invention is firstly sprayed on the A pot to act on Shenshu, Zhongwan and Shenque acupoints, sparrow pecking moxibustion and mild moxibustion are alternately adopted for moxibustion, each acupoint is used for moxibustion for 10-30 minutes, and then the B pot is uniformly sprayed on the pain part for moxibustion for 10-30 minutes. After continuous use for 2 months, the symptoms are improved, and after continuous use for 4 months, the patient can move freely without relapse in follow-up visit at later stage.
2. A certain bear, a woman in the age of 60, swollen double knee joints, deformed bones and pain which are severe when encountering cold, test resistance of a hospital is 800 units, the spraying moxibustion composition is firstly sprayed into the A pot to act on Shenshu, Zhongwan and Shenque acupoints, sparrow pecking moxibustion and mild moxibustion are alternately used for moxibustion, each acupoint is used for moxibustion for 10-30 minutes, and then the B pot is uniformly sprayed on the pain part for moxibustion for 10-30 minutes. After 1 month of use, the pain is relieved, after 3 months of continuous use, the pain is cured, the anti-O is reduced to 400 units, and the disease does not relapse after follow-up at the later stage.
3. The symptoms of a male, 51 years old are manifested as pain in joints of various parts of the whole body, especially the deformity of joints of both hands is accompanied by numbness and stiffness, oral administration of the anti-inflammatory analgesic drug has no fruits, the spray moxibustion composition disclosed by the invention is firstly sprayed on the A pot to act on Shenshu, Zhongwan and Shenque acupoints, sparrow pecking moxibustion and mild moxibustion are alternately used for moxibustion, each acupoint is used for moxibustion for 10-30 minutes, and then the B pot is uniformly sprayed on the pain part for moxibustion for 10-30 minutes. After 2 months of continuous use, the joint pain is relieved, the symptoms are obviously improved, after 3 months of continuous use, the joint pain basically returns to normal, and the disease does not relapse after follow-up visit in the later period.
Although the present invention has been described in detail with reference to the above description, the design concept of the present invention is not limited thereto. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. The present invention is not limited to the above embodiments, and various modifications and changes may be made without departing from the spirit and scope of the present invention.
Claims (5)
1. A targeted moxibustion composition for treating rheumatoid arthritis is characterized in that: comprises a pot A and a pot B, wherein the pot A comprises Kunlun Muyu powder, pubescent angelica root, notoginseng, angelica, safflower, cassia twig, clematis root, Loranthus mulberry mistletoe, eucommia bark, dahurian angelica root, asarum, white peony root and astragalus root, the pot B comprises cassia twig, dried body of ground beetle, cyathula root, achyranthes root, atractylodes rhizome, ephedra, batryticated silkworm, frankincense, myrrh, calcined pyrite, angelica, safflower, Ligusticum wallichii, rhizome of rehmannia, notopterygium root, dried ginger, tetrandra root, clematis root, medlar, eucommia bark, large-leaf gentian root, homalomena rhizome, arisaema tuber, siegesbeckia herb, pawpaw, earthworm, pubescent angelica root, dipsacus root.
3. the preparation method of the targeted moxibustion composition for treating rheumatoid arthritis according to any one of claims 1 to 2, which is characterized by comprising the following steps: the method comprises the following steps:
s01: baking with slow fire: weighing the components of the composition according to the weight part ratio, cleaning, adding auxiliary materials, stirring uniformly, adding into a container fired by adding clay, medical stone powder and jasper powder, sealing with yellow mud, and baking in a baking room at 35-65 ℃;
s02: nano-crushing: adding high-boron deuterium-depleted water, and micronizing at 25 deg.C to obtain suspension containing Chinese medicinal particles with nanometer particle size;
s03: and (3) sterilization and filling: short-time microwave sterilization, high-boron deuterium-depleted water dilution, pressurization filling and spray preparation.
4. The preparation method of the targeted moxibustion composition for treating rheumatoid arthritis according to claim 3, wherein the preparation method comprises the following steps: s01 the adjuvants include one or more of Mel, yellow wine, testa Tritici, salt, and vinegar.
5. The use method of the targeted moxibustion composition for treating rheumatoid arthritis according to any one of claims 1 to 2, wherein the composition comprises the following components: firstly spraying the pot A to act on Shenshu, Zhongwan and Shenque acupoints, performing moxibustion alternately by sparrow pecking moxibustion and mild moxibustion for 10-30 minutes, and then uniformly spraying the pot B on the pain part for 10-30 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010853302.9A CN111840383A (en) | 2020-08-23 | 2020-08-23 | Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010853302.9A CN111840383A (en) | 2020-08-23 | 2020-08-23 | Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111840383A true CN111840383A (en) | 2020-10-30 |
Family
ID=72969730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010853302.9A Pending CN111840383A (en) | 2020-08-23 | 2020-08-23 | Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111840383A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111840317A (en) * | 2020-08-23 | 2020-10-30 | 刘东泰 | Targeted spray moxibustion composition for treating hypertension and preparation and use methods thereof |
CN111840318A (en) * | 2020-08-23 | 2020-10-30 | 刘东泰 | Targeted moxibustion composition for treating male sexual dysfunction and preparation and use methods thereof |
CN111939173A (en) * | 2020-08-23 | 2020-11-17 | 刘东泰 | Targeted spray moxibustion composition for treating skin diseases and preparation and use methods thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101306003A (en) * | 2008-04-15 | 2008-11-19 | 天津市尖峰天然产物研究开发有限公司 | Use of cyaniding 3-0 glucoside in preparing medicament or food for preventing and curing atrophic arthritis |
CN111840318A (en) * | 2020-08-23 | 2020-10-30 | 刘东泰 | Targeted moxibustion composition for treating male sexual dysfunction and preparation and use methods thereof |
CN111905088A (en) * | 2020-08-23 | 2020-11-10 | 刘东泰 | Targeted spray moxibustion composition for treating alopecia and preparation and use methods thereof |
-
2020
- 2020-08-23 CN CN202010853302.9A patent/CN111840383A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101306003A (en) * | 2008-04-15 | 2008-11-19 | 天津市尖峰天然产物研究开发有限公司 | Use of cyaniding 3-0 glucoside in preparing medicament or food for preventing and curing atrophic arthritis |
CN111840318A (en) * | 2020-08-23 | 2020-10-30 | 刘东泰 | Targeted moxibustion composition for treating male sexual dysfunction and preparation and use methods thereof |
CN111905088A (en) * | 2020-08-23 | 2020-11-10 | 刘东泰 | Targeted spray moxibustion composition for treating alopecia and preparation and use methods thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111840317A (en) * | 2020-08-23 | 2020-10-30 | 刘东泰 | Targeted spray moxibustion composition for treating hypertension and preparation and use methods thereof |
CN111840318A (en) * | 2020-08-23 | 2020-10-30 | 刘东泰 | Targeted moxibustion composition for treating male sexual dysfunction and preparation and use methods thereof |
CN111939173A (en) * | 2020-08-23 | 2020-11-17 | 刘东泰 | Targeted spray moxibustion composition for treating skin diseases and preparation and use methods thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178895B (en) | Chinese medicine composition for treating orthopedic disorders and preparation method thereof | |
CN104288538A (en) | Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster | |
CN111840383A (en) | Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof | |
CN106309611A (en) | Plaster with effects of relaxing muscles and stimulating blood circulation | |
CN100366278C (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
CN1325110C (en) | Medicated wine for treating traumatic injury | |
CN104383445A (en) | Traumatic injury analgesic | |
CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
CN102961539B (en) | Plaster for treating wind-cold-dampness arthralgia and preparation method thereof | |
CN102406870A (en) | Medicine for treating rheumatic arthralgia | |
CN109908245A (en) | It is a kind of for treating the Chinese medicine composition of neck-shoulder pain, lumbago and leg pain disease | |
CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
CN104288597A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
CN114681551B (en) | Traditional Chinese medicine composition for treating arthralgia and myalgia, preparation and application thereof | |
CN1181835C (en) | Chinese medicine preparation for treating rheumatism and rheumatoid disease | |
CN108245564B (en) | Black plaster and preparation method thereof | |
CN106039236A (en) | Traditional Chinese medicine preparation for treating bone cancer and improving immunity, and preparation method of traditional Chinese medicine preparation | |
CN103341098B (en) | Traditional Chinese medicine for treating tinea pedes | |
CN104547947A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
CN105362986A (en) | Traditional Chinese medicine composition for treating rheumatism cold disease | |
CN105169054A (en) | Traditional Chinese medicine preparation for treating acute and chronic osteoarthritis and preparation method thereof | |
CN116920064A (en) | Traditional Chinese medicine formula for treating rheumatic bone diseases and processing method thereof | |
CN105106692A (en) | Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201030 |
|
RJ01 | Rejection of invention patent application after publication |